Matches in Nanopublications for { ?s ?p "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- NP676488.RABnKPiyW5LV7_BAc9wRgc6kZDw7wWJLCMPPCLaYAukMg130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676488.RABnKPiyW5LV7_BAc9wRgc6kZDw7wWJLCMPPCLaYAukMg130_provenance.
- NP280468.RAVkuJVL41ANjU0f52pddoXlpp89j0jAwm4l0ryHveF98130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280468.RAVkuJVL41ANjU0f52pddoXlpp89j0jAwm4l0ryHveF98130_provenance.
- NP701819.RAdWvfXNvgEovoNNiYmxeRrYnwRG4X80P2gshkwJ5B_xg130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701819.RAdWvfXNvgEovoNNiYmxeRrYnwRG4X80P2gshkwJ5B_xg130_provenance.
- NP346657.RAazyCSos6mMlbgovFqTaBILJsH0V80NIwd0lJ_OqIQjQ130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346657.RAazyCSos6mMlbgovFqTaBILJsH0V80NIwd0lJ_OqIQjQ130_provenance.
- NP595375.RA-h947nctB_XEPkmpadRJSzqERgG56OXqn6x0S6dgXX0130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595375.RA-h947nctB_XEPkmpadRJSzqERgG56OXqn6x0S6dgXX0130_provenance.
- assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP991826.RAcDaN45g88KRGYwCm3Vx-Ey-nEQDtIdqHEqrwZXmBIHs130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991826.RAcDaN45g88KRGYwCm3Vx-Ey-nEQDtIdqHEqrwZXmBIHs130_provenance.
- NP992062.RAAp7VPw_3CWDngiTxswZdZTFLejrUHO-9IWG8abUlIow130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992062.RAAp7VPw_3CWDngiTxswZdZTFLejrUHO-9IWG8abUlIow130_provenance.
- NP839723.RAN9NghrIfGvGvUZp9D4JpI-IC_L1Ln167R8B3x1Gk74E130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839723.RAN9NghrIfGvGvUZp9D4JpI-IC_L1Ln167R8B3x1Gk74E130_provenance.
- NP930610.RAPHKp_9G6q4vcAVKdrLH2dLG-LVPvVhT75CuKFmxFTRo130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930610.RAPHKp_9G6q4vcAVKdrLH2dLG-LVPvVhT75CuKFmxFTRo130_provenance.
- NP309357.RAA3guAt4WfkBF7ivg3Ck6oepH3uGNVp8mpG_5wmClDKE130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309357.RAA3guAt4WfkBF7ivg3Ck6oepH3uGNVp8mpG_5wmClDKE130_provenance.
- assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP991937.RAifRnopyf1q0zkh_0Ngv6nQcYAx393bZU78AnW5NFb3A130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991937.RAifRnopyf1q0zkh_0Ngv6nQcYAx393bZU78AnW5NFb3A130_provenance.
- NP830140.RAgpNCT-iigfJR3A14vIaiQO-rgPCjHhQhOIfCAxlY8qM130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830140.RAgpNCT-iigfJR3A14vIaiQO-rgPCjHhQhOIfCAxlY8qM130_provenance.
- NP992059.RA6IX_PAc_Gikj0vDbsqvWxqqrvXpv6ajNlQSbSNRaqj4130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992059.RA6IX_PAc_Gikj0vDbsqvWxqqrvXpv6ajNlQSbSNRaqj4130_provenance.
- NP830142.RAGr3RxUtfHzn9v0Cw8kSof6Fj2yjWby837pfxMr4XVh0130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830142.RAGr3RxUtfHzn9v0Cw8kSof6Fj2yjWby837pfxMr4XVh0130_provenance.
- NP830139.RA3IoD4TDXiLgSo3e4Q5FvKUCgr__t-222Wc9dzoCEPEE130_assertion description "[We report here that an alphavirus vector, packaged in virus-like replicon particles (VRP) and capable of efficiently infecting DCs, could be repeatedly administered to patients with metastatic cancer expressing the tumor antigen carcinoembryonic antigen (CEA) and that it overcame high titers of neutralizing antibodies and elevated Treg levels to induce clinically relevant CEA-specific T cell and antibody responses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830139.RA3IoD4TDXiLgSo3e4Q5FvKUCgr__t-222Wc9dzoCEPEE130_provenance.